MedTrace Logo

Counseling on Injectable Contraception and HIV Risk in Tanzania

NCT04160169 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2019-11-12

No results posted yet for this study

Summary

The main objective of the evaluation was to assess the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and behavior during a three month pilot intervention in ten healthcare facilities in Tanzania.

Conditions

  • Contraception

Interventions

OTHER

Counseling messages on injectable use and HIV acquisition risk

Counseling messages based on 2017 World Health Organization guidance, a review of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-related Risks, and the Family Planning Global Handbook were provided to clients expressing interest in injectables during regular family planning appointments.

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Ministry of Health, Tanzania

    collaborator OTHER_GOV

  • Johns Hopkins Bloomberg School of Public Health

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Janine Barden-O'Fallon, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Tanzania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04160169 on ClinicalTrials.gov